Persistent de Quervain tenosynovitis induced by somatotropin treatment

Yurdakul O. V. , Ayture L., YALCINKAYA E. Y.

JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, vol.30, no.11, pp.1223-1226, 2017 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 30 Issue: 11
  • Publication Date: 2017
  • Doi Number: 10.1515/jpem-2017-0085
  • Title of Journal : JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
  • Page Numbers: pp.1223-1226

Abstract

Background: Growth hormone deficiency is a well-known clinical entity that is usually treated with somatotropin (growth hormone). Growth hormone has some frequent side effects such as intracranial hypertension, lymphedema and diabetes mellitus.